{"entity":{"type":"insider","cik":"0001796290","url":"/insider/0001796290","json_url":"/insider/0001796290.json","name":"Butchko Julia G.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":24,"first":"2020-09-15","last":"2024-08-23","span_basis":"filed_date"},"name_variants":[{"name":"Butchko Julia G.","source":"filing","n_filings":24,"first_seen":"2020-09-15","last_seen":"2024-08-23"}],"transactions":[{"id":2050429,"accession":"0001764013-24-000157","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000157","line_url":"/filing/0001764013-24-000157","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3027.0,"shares_display":"3,027","price_per_share":31.859028741328046,"price_display":"31.86","price_state":"stated","total_value":96437.28,"total_display":"96,437.28","total_whole":"96,437","shares_owned_after":441079.0,"shares_owned_after_display":"441,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-23","scope":"insider","n_lines":2},{"id":2227848,"accession":"0001764013-24-000134","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000134","line_url":"/filing/0001764013-24-000134","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2867.0,"shares_display":"2,867","price_per_share":29.693641437042203,"price_display":"29.69","price_state":"stated","total_value":85131.67,"total_display":"85,131.67","total_whole":"85,132","shares_owned_after":444155.0,"shares_owned_after_display":"444,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-19","scope":"insider","n_lines":2},{"id":2747769,"accession":"0001764013-24-000126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000126","line_url":"/filing/0001764013-24-000126#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1527.0,"shares_display":"1,527","price_per_share":28.06,"price_display":"28.06","price_state":"stated","total_value":42847.62,"total_display":"42,847.62","total_whole":"42,848","shares_owned_after":446853.0,"shares_owned_after_display":"446,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-09","filed_date":"2024-07-10","scope":"insider"},{"id":2663979,"accession":"0001764013-24-000097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000097","line_url":"/filing/0001764013-24-000097#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3247.0,"shares_display":"3,247","price_per_share":29.65,"price_display":"29.65","price_state":"stated","total_value":96273.55,"total_display":"96,273.55","total_whole":"96,274","shares_owned_after":448380.0,"shares_owned_after_display":"448,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-22","filed_date":"2024-05-24","scope":"insider"},{"id":2747763,"accession":"0001764013-24-000077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000077","line_url":"/filing/0001764013-24-000077","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10115.0,"shares_display":"10,115","price_per_share":29.058091942659416,"price_display":"29.06","price_state":"stated","total_value":293922.6,"total_display":"293,922.60","total_whole":"293,923","shares_owned_after":453917.0,"shares_owned_after_display":"453,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-17","filed_date":"2024-04-19","scope":"insider","n_lines":2},{"id":2747756,"accession":"0001764013-24-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000071","line_url":"/filing/0001764013-24-000071#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1053.0,"shares_display":"1,053","price_per_share":31.18,"price_display":"31.18","price_state":"stated","total_value":32832.54,"total_display":"32,832.54","total_whole":"32,833","shares_owned_after":461742.0,"shares_owned_after_display":"461,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-09","filed_date":"2024-04-10","scope":"insider"},{"id":3101286,"accession":"0001764013-24-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000038","line_url":"/filing/0001764013-24-000038#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2146.0,"shares_display":"2,146","price_per_share":36.15,"price_display":"36.15","price_state":"stated","total_value":77577.9,"total_display":"77,577.90","total_whole":"77,578","shares_owned_after":407817.0,"shares_owned_after_display":"407,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-22","filed_date":"2024-02-23","scope":"insider"},{"id":2050421,"accession":"0001764013-24-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000007","line_url":"/filing/0001764013-24-000007#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1297.0,"shares_display":"1,297","price_per_share":38.59,"price_display":"38.59","price_state":"stated","total_value":50051.23,"total_display":"50,051.23","total_whole":"50,051","shares_owned_after":409963.0,"shares_owned_after_display":"409,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-09","scope":"insider"},{"id":8379439,"accession":"0001764013-23-000141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000141","line_url":"/filing/0001764013-23-000141","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3265.0,"shares_display":"3,265","price_per_share":32.77924349157733,"price_display":"32.78","price_state":"stated","total_value":107024.23,"total_display":"107,024.23","total_whole":"107,024","shares_owned_after":411384.0,"shares_owned_after_display":"411,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-24","scope":"insider","n_lines":2},{"id":7984697,"accession":"0001764013-23-000118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000118","line_url":"/filing/0001764013-23-000118","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1735.0,"shares_display":"1,735","price_per_share":36.2449855907781,"price_display":"36.24","price_state":"stated","total_value":62885.05,"total_display":"62,885.05","total_whole":"62,885","shares_owned_after":414525.0,"shares_owned_after_display":"414,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-05","filed_date":"2023-10-06","scope":"insider","n_lines":2},{"id":8618052,"accession":"0001764013-23-000101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000101","line_url":"/filing/0001764013-23-000101","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12333.0,"shares_display":"12,333","price_per_share":20.300047839130787,"price_display":"20.30","price_state":"stated","total_value":250360.49,"total_display":"250,360.49","total_whole":"250,360","shares_owned_after":416261.0,"shares_owned_after_display":"416,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-25","scope":"insider","n_lines":2},{"id":7953375,"accession":"0001764013-23-000077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000077","line_url":"/filing/0001764013-23-000077#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1470.0,"shares_display":"1,470","price_per_share":19.73,"price_display":"19.73","price_state":"stated","total_value":29003.1,"total_display":"29,003.10","total_whole":"29,003","shares_owned_after":428593.0,"shares_owned_after_display":"428,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-13","scope":"insider"},{"id":8049688,"accession":"0001764013-23-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000051","line_url":"/filing/0001764013-23-000051#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1544.0,"shares_display":"1,544","price_per_share":15.27,"price_display":"15.27","price_state":"stated","total_value":23576.88,"total_display":"23,576.88","total_whole":"23,577","shares_owned_after":430063.0,"shares_owned_after_display":"430,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-18","filed_date":"2023-04-19","scope":"insider"},{"id":8270601,"accession":"0001764013-23-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000010","line_url":"/filing/0001764013-23-000010","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Dev. & Tech. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Tech. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60490.0,"shares_display":"60,490","price_per_share":16.78948801454786,"price_display":"16.79","price_state":"stated","total_value":1015596.13,"total_display":"1,015,596.13","total_whole":"1,015,596","shares_owned_after":331419.0,"shares_owned_after_display":"331,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-13","scope":"insider","n_lines":2},{"id":6136569,"accession":"0001764013-22-000132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000132","line_url":"/filing/0001764013-22-000132#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Dev. & Tech. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Tech. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":928.0,"shares_display":"928","price_per_share":9.18,"price_display":"9.18","price_state":"stated","total_value":8519.04,"total_display":"8,519.04","total_whole":"8,519","shares_owned_after":391909.0,"shares_owned_after_display":"391,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-17","scope":"insider"},{"id":6500477,"accession":"0001764013-22-000124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000124","line_url":"/filing/0001764013-22-000124#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Dev. & Tech. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Tech. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":535.0,"shares_display":"535","price_per_share":4.67,"price_display":"4.67","price_state":"stated","total_value":2498.45,"total_display":"2,498.45","total_whole":"2,498","shares_owned_after":392837.0,"shares_owned_after_display":"392,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-29","scope":"insider"},{"id":6910013,"accession":"0001764013-22-000111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000111","line_url":"/filing/0001764013-22-000111#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Dev. & Tech. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Tech. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":548.0,"shares_display":"548","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":3194.84,"total_display":"3,194.84","total_whole":"3,195","shares_owned_after":393372.0,"shares_owned_after_display":"393,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-30","filed_date":"2022-09-01","scope":"insider"},{"id":6529504,"accession":"0001764013-22-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000078","line_url":"/filing/0001764013-22-000078#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Dev. & Tech. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Tech. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":510.0,"shares_display":"510","price_per_share":4.27,"price_display":"4.27","price_state":"stated","total_value":2177.7,"total_display":"2,177.70","total_whole":"2,178","shares_owned_after":281104.0,"shares_owned_after_display":"281,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-27","filed_date":"2022-07-29","scope":"insider"},{"id":6363580,"accession":"0001764013-22-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000071","line_url":"/filing/0001764013-22-000071#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Dev. & Tech. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Tech. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":460.0,"shares_display":"460","price_per_share":4.02,"price_display":"4.02","price_state":"stated","total_value":1849.2,"total_display":"1,849.20","total_whole":"1,849","shares_owned_after":281614.0,"shares_owned_after_display":"281,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-29","filed_date":"2022-07-01","scope":"insider"},{"id":6584731,"accession":"0001764013-22-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000047","line_url":"/filing/0001764013-22-000047#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Dev. & Tech. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Tech. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":492.0,"shares_display":"492","price_per_share":3.79,"price_display":"3.79","price_state":"stated","total_value":1864.68,"total_display":"1,864.68","total_whole":"1,865","shares_owned_after":282074.0,"shares_owned_after_display":"282,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-25","scope":"insider"},{"id":6231346,"accession":"0001764013-22-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000043","line_url":"/filing/0001764013-22-000043#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Dev. & Tech. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Tech. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":541.0,"shares_display":"541","price_per_share":4.72,"price_display":"4.72","price_state":"stated","total_value":2553.52,"total_display":"2,553.52","total_whole":"2,554","shares_owned_after":282566.0,"shares_owned_after_display":"282,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-27","filed_date":"2022-04-29","scope":"insider"},{"id":6402914,"accession":"0001764013-22-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000037","line_url":"/filing/0001764013-22-000037#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Dev. & Tech. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Tech. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6381.0,"shares_display":"6,381","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":37647.9,"total_display":"37,647.90","total_whole":"37,648","shares_owned_after":283107.0,"shares_owned_after_display":"283,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-24","filed_date":"2022-04-14","scope":"insider"},{"id":6941405,"accession":"0001764013-22-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000013","line_url":"/filing/0001764013-22-000013#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Dev. & Tech. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Tech. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55318.0,"shares_display":"55,318","price_per_share":7.25,"price_display":"7.25","price_state":"stated","total_value":401055.5,"total_display":"401,055.50","total_whole":"401,056","shares_owned_after":289488.0,"shares_owned_after_display":"289,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-11","scope":"insider"},{"id":2768389,"accession":"0001764013-20-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-20-000037","line_url":"/filing/0001764013-20-000037#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796290","owner_name":"Butchko Julia G.","owner_display_name":"Butchko Julia G.","owner_url":"/insider/0001796290","role":"Officer (Chief Dev. & Tech. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Tech. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Tech. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":38.17,"price_display":"38.17","price_state":"stated","total_value":190850.0,"total_display":"190,850.00","total_whole":"190,850","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-11","filed_date":"2020-09-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001764013","name":"Immunovant, Inc.","url":"/issuer/0001764013","role":"Officer (Chief Development Officer)","n_filings":24,"first_seen":"2020-09-15","last_seen":"2024-08-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001796290","retrieved_at":"2026-08-24T21:34:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}